33 related articles for article (PubMed ID: 1318201)
1. Positive selection of T-lymphocytes induced by intrathymic injection of a thymic epithelial cell line.
Vukmanović S; Grandea AG; Faas SJ; Knowles BB; Bevan MJ
Nature; 1992 Oct; 359(6397):729-32. PubMed ID: 1331804
[TBL] [Abstract][Full Text] [Related]
2. Recognition of the Qa-2k tumor antigen by T cell receptor gamma/delta of an immunopotentiator-induced tumoricidal T cell of mice.
Okazaki T; Nakanishi-Ito C; Seo N; Tanino T; Takiguchi M; Egawa K
Cancer Immunol Immunother; 1993; 36(2):83-8. PubMed ID: 8425212
[TBL] [Abstract][Full Text] [Related]
3. The three-dimensional structure of a T-cell antigen receptor V alpha V beta heterodimer reveals a novel arrangement of the V beta domain.
Housset D; Mazza G; Grégoire C; Piras C; Malissen B; Fontecilla-Camps JC
EMBO J; 1997 Jul; 16(14):4205-16. PubMed ID: 9250664
[TBL] [Abstract][Full Text] [Related]
4. Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL).
Smith PA; Brunmark A; Jackson MR; Potter TA
J Exp Med; 1997 Mar; 185(6):1023-33. PubMed ID: 9091576
[TBL] [Abstract][Full Text] [Related]
5. Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptides.
Sherman LA; Chattopadhyay S; Biggs JA; Dick RF; Bluestone JA
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):6949-51. PubMed ID: 8346201
[TBL] [Abstract][Full Text] [Related]
6. A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations.
Dal Porto J; Johansen TE; Catipović B; Parfiit DJ; Tuveson D; Gether U; Kozlowski S; Fearon DT; Schneck JP
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6671-5. PubMed ID: 8341685
[TBL] [Abstract][Full Text] [Related]
7. Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivity.
Chattopadhyay S; Theobald M; Biggs J; Sherman LA
J Exp Med; 1994 Jan; 179(1):213-9. PubMed ID: 8270866
[TBL] [Abstract][Full Text] [Related]
8. Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition.
Bluestone JA; Jameson S; Miller S; Dick R
J Exp Med; 1992 Dec; 176(6):1757-61. PubMed ID: 1460430
[TBL] [Abstract][Full Text] [Related]
9. Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.
Höglund P; Ljunggren HG; Kärre K; Jay G
Immunol Res; 1990; 9(4):298-313. PubMed ID: 2089075
[No Abstract] [Full Text] [Related]
10. Direct analysis of peptide binding to cell-associated MHC class I molecules.
Cerottini JC; Luescher IF
Immunol Lett; 1991 Oct; 30(2):171-5. PubMed ID: 1836776
[TBL] [Abstract][Full Text] [Related]
11. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
[TBL] [Abstract][Full Text] [Related]
12. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
[TBL] [Abstract][Full Text] [Related]
13. The role of self peptides in the allogeneic cross-reactivity of CTLs.
Kuzushima K; Sun R; van Bleek GM; Vegh Z; Nathenson SG
J Immunol; 1995 Jul; 155(2):594-601. PubMed ID: 7541821
[TBL] [Abstract][Full Text] [Related]
14. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
Zügel U; Schoel B; Kaufmann SH
J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
[TBL] [Abstract][Full Text] [Related]
15. Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.
Aosai F; Ohlen C; Ljunggren HG; Höglund P; Franksson L; Ploegh H; Townsend A; Kärre K; Stauss HJ
Eur J Immunol; 1991 Nov; 21(11):2767-74. PubMed ID: 1936122
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
